02188nas a2200265 4500000000100000008004100001260004400042653002000086653003600106653002600142653001400168653001300182100001200195700001500207700001200222700001600234700001300250700001500263245012600278856006900404300001400473490000700487520140300494022002501897 2026 d c05/2026bUniversitas Al Azhar Indonesia10aSlit-skin smear10aPolymerase Chain Reaction (PCR)10aMycobacterium leprae 10aDiagnosis10a Leprosy1 aSari IM1 aAzzahra SF1 aZahro F1 aSalsabila L1 a'Aini SM1 aMutiara RA00aAssessing the Accuracy of PCR and Slit-Skin Smear Methods for Diagnosing Suspected Leprosy: An Evidence-Based Case Report uhttps://jurnal.uai.ac.id/index.php/SST/article/download/5079/pdf a155 - 1620 v113 a

Leprosy (Hansen’s disease) is a chronic infectious condition caused by Mycobacterium leprae, affecting the skin, peripheral nerves, and mucosa. The slit-skin smear (SSS) is a standard diagnostic method but has limited sensitivity, especially in paucibacillary cases. Polymerase Chain Reaction (PCR) offers higher sensitivity by detecting M. leprae DNA, even in early or subclinical infections. This study aimed to compare the diagnostic accuracy of PCR and SSS in suspected leprosy cases. This Evidence-Based Case Report (EBCR) was developed through a structured literature search and critical appraisal of diagnostic accuracy studies using PubMed and Cochrane databases. Eligible cross-sectional studies comparing PCR and SSS were critically appraised for validity, relevance and applicability based on OCEBM and QUADAS-2. Two studies met the inclusion criteria and were analyzed based on sensitivity and specificity for M. leprae detection. Both studies demonstrated that PCR had markedly higher sensitivity than SSS. Khatoon et al. (2021) reported PCR detecting 66% of cases versus 34% by SSS, while Siwakoti et al. (2016) found 72% versus 18%, respectively. PCR exhibits advantages diagnostic accuracy compared to SSS, particularly for early or paucibacillary leprosy. Although more costly, PCR is recommended as a confirmatory tool to enhance early diagnosis and prevent disability.

 a2355-8059, 2087-9725